Efficacy of Different Combinations of Direct-Acting Antivirals Against Different Hepatitis C Virus-Infected Population Groups: An Experience in Tertiary Care Hospitals in West Bengal, India

Hepatitis C virus (HCV) is a global public health problem, but advancements in HCV treatment have improved the cure rate. This study evaluated the effectiveness of direct-acting antivirals (DAAs) in HCV-infected patients from May 2021 to April 2023 in collaboration with tertiary care hospitals in We...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Sagnik Bakshi, Partha Chattopadhyay, Mahiuddin Ahammed, Raina Das, Moumita Majumdar, Supradip Dutta, Shreyasi Nath, Anwesha Ghosh, Uttaran Bhattacharjee, Upasana Baskey, Provash Chandra Sadhukhan
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2025-02-01
Edice:	Viruses
Témata:	direct-acting antivirals (DAAs) genotypes Hepatitis C virus (HCV) non-responder sustained virologic response (SVR)
On-line přístup:	https://www.mdpi.com/1999-4915/17/2/269
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!